Aligning Science Across Parkinson's Logo Text

News & Updates

Sort

  • Search
  • Type
  • Program
  • CRN Team Name
  • Topics

ASAP Research Round-Up | Q3 2026

In this Q3 2026 edition of the ASAP Research Round-Up, we highlight how our programs produced resources for the scientific community, created opportunities for collaboration, and helped researchers accelerate discoveries in Parkinson’s disease (PD) research.

October 29, 2026

Read More
Q3ResearchRound-Up-Graphic

MoMa Awardees Tackle Meta-Analysis of CRN Omics Data

Guided by our open science approach, ASAP launched the Multi-Omics Meta-Analysis (MoMa) funding opportunity to support Collaborative Research Network (CRN) researchers interested in conducting meta-analysis of omics data housed within our publicly accessible database, the CRN Cloud.

October 28, 2026

Read More
ASAP 2025 and 2026 Multi-Omics Meta-Analysis (MoMa) Cohorts.

Voices From the Network: How Open Science Practices Are Driving Research Forward

To celebrate Open Science Week, ASAP highlights how transparent collaboration and open data sharing are driving research forward across our network to accelerate Parkinson's discoveries.

September 16, 2026

Read More
Voices From the Network: How Open Science Practices Are Driving Research Forward

Study Points to Genetic Variant in Over 25% of Ashkenazi Jews With Parkinson’s

The Jewish Chronicle highlights a Lancet study by Global Parkinson's Genetics Program (GP2), a resource program of ASAP, which represents the largest-ever global assessment of Parkinson’s genetics across 11 ancestries and reveals that a specific variant is present in over 25% of Ashkenazi Jews with the condition.

September 6, 2026

View Story

Expanding Our Research Horizons: 2026 CRN Investigators Meeting

In this blog, Hetal Shah, PhD, senior program officer, and Dana Lewis, PhD, program officer at ASAP and the Coalition for Aligning Science, discuss highlights from the 2026 CRN Annual Investigators Meeting, emphasizing how new research themes and cross-disciplinary collaboration are accelerating progress in Parkinson’s disease research.

September 2, 2026

Read More

Hidden Gene in Middle East Populations Can Signal Parkinson’s Disease

The National highlights a Lancet study by the Global Parkinson’s Genetics Program (GP2), a resource program of ASAP, revealing significant blind spots in addressing the needs of Middle Eastern populations, despite high regional rates of key genetic variants linked to Parkinson’s disease.

September 1, 2026

View Story
The National logo.

Sparking Discoveries for Parkinson’s Research: CRN Impact Report 2025-2026

In this blog, ASAP shares an overview of the Collaborative Research Network (CRN) 2025–2026 Impact Report, highlighting key discoveries, cross-cutting scientific themes, field-enabling resources, and infrastructure efforts accelerating breakthroughs in Parkinson's disease research.

August 24, 2026

Read More
CRN Impact Report 2025-2026

Parkinson’s Research Funders Lead the Way With Progressive Open Access and Open Science Policies

SPARC dives into how Aligning Science Across Parkinson's (ASAP) and The Michael J. Fox Foundation (MJFF) are advancing Parkinson's research through open-access and open-science policies that mandate the early, public sharing of publications, data, protocols, and lab resources.

August 19, 2026

View Story
SPARC logo.

More Than One in Four Ashkenazi Parkinson’s Patients Carry Genetic Risk Variant

The Jewish News reports on a study by the Global Parkinson’s Genetics Program (GP2), a resource program of ASAP, showing the role genetics plays in Parkinson’s in Jewish patients and how they are well placed to benefit from emerging precision treatments.

August 14, 2026

View Story
Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.